AtriCure upgraded to Overweight from Neutral at Piper Jaffray Piper Jaffray upgraded AtriCure citing confidence in new management after meeting with the company's new CEO Michael Carrel. Piper raised its price target for shares to $10 from $6.
AtriCure names Douglas Seith as COO and Andy Wade as CFO AtriCure, Inc. announced that Douglas Seith will assume the role of COO. Douglas Seith will now be responsible for all global commercial organizations as well as education and clinical science programs. The company also announced that Andy Wade has been promoted to senior VP and CFO.